Here's a statement of the obvious: The opinions expressed here are those of the participants, not those of the Mutual Fund Observer. We cannot vouch for the accuracy or appropriateness of any of it, though we do encourage civility and good humor.
Support MFO
Donate through PayPal
IndexIQ Deal Highlights Growth In Alternative ETFs
FYI: (Follow-Up Article) New York Life plunked down an undisclosed sum to buy IndexIQ last week. Announcing the acquisition, the mega insurer touted the small $1.5 billion ETF provider's expertise in alternative investing. Increasingly, investors expect more for their portfolios than just core holdings with pure beta exposures, said Adam Patti, CEO of IndexIQ, which will be folded into New York Life's MainStay Investments subsidiary after the deal closes in the first half of 2015. Regards, Ted http://license.icopyright.net/user/viewFreeUse.act?fuid=MTg3MzkxMjU=
